简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2016-10-10 10:56 Herbalife Nutrition Asia Pacific Survey Reveals That Millennials Find It Difficult to Engage in Physical Activities in the Modern Workplace
2016-10-10 10:36 Samsung Bioepis' Marketing Authorization Application for SB3 Trastuzumab Biosimilar Candidate Accepted for Review by the European Medicines Agency
2016-09-30 10:34 InCellis: The New Age of Cell Imaging by BERTIN
2016-09-30 10:18 Boehringer Ingelheim and Sarah Cannon Research Institute launch strategic collaboration to develop novel immune-oncology therapies
2016-09-29 09:59 Boehringer Ingelheim Boosts Immune-Oncology Pipeline Through Collaboration with ViraTherapeutics
2016-09-27 17:02 Herbalife Nutrition and Special Olympics Announce $1 Million Fitness Collaboration
2016-09-23 18:30 Alexion Employees Volunteer Together in Company’s First Global Day of Service
2016-09-23 11:26 AGS FX Creations Electric Motorsport Backpack
2016-09-22 16:12 OT Supplies SESAM-Vitale in France With More Than 7 Million Health Cards a Year
2016-09-22 15:57 SAB Biotherapeutics' Immunotherapy Proposal among Top Platform Technology Solutions in WHO Report
2016-09-21 16:19 Smith & Nephew Reinforces Strong Educational Commitment to Advanced Wound Management at World Union of Wound Healing Societies Meeting (WUWHS)
2016-09-21 10:50 Takeda and Zydus Cadila partner to address the global threat of Chikungunya
2016-09-21 10:37 New survey reveals 9 out of 10 patients with IPF were happy with how their doctor told them about their IPF diagnosis
2016-09-21 10:08 One-Year Results in Japanese Clinical Study Affirms the GORE® VIABAHN® Endoprosthesis as a Device-of-Choice for Treating Complex SFA Disease
2016-09-20 17:31 First Implant Completed in Pivotal Study of GORE® TAG® Thoracic Branch Endoprosthesis
2016-09-20 16:54 Second Global NCD Alliance Forum to be Held in Sharjah, UAE in December 2017
2016-09-20 10:40 Biopharmaceutical Industry Calls the Recommendations of UN High Level Panel on Access to Medicines a Missed Opportunity to Genuinely Address Patients’ Needs
2016-09-19 11:13 Oral Ozanimod Efficacy and Safety Results at 2 Years from Phase 2 RADIANCE Trial of Patients with Relapsing Multiple Sclerosis Presented at 32nd ECTRIMS
2016-09-19 11:08 Takeda Receives Positive CHMP Opinion for Conditional Approval of NINLAROTM (ixazomib), the First Oral Proteasome Inhibitor, for Use in Patients with Multiple Myeloma
2016-09-19 10:54 Glyxambi® (empagliflozin/linagliptin) approval recommended by CHMP for adults with type 2 diabetes in the European Union

Business Wire Weibo

Press Releases

Latest Releases